Skip to main content

Provider

By HIMSS TV | 07:00 am | December 27, 2023
Brian Esterly, CEO of TimeDoc Health, discusses health IT's role in bringing together patients and care teams and facilitating self-care management, particularly for patients with chronic conditions in healthcare deserts.  
By Jessica Hagen | 10:39 pm | December 26, 2023
Employers aligned with Carrum can offer two years of treatment coverage to non-metastatic breast cancer patients via Florida Cancer Specialists & Research Institute.
By Jessica Hagen | 01:41 pm | December 26, 2023
Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.
By HIMSS TV | 07:00 am | December 26, 2023
Thomas Hallisey, HANYS digital health strategy lead, discusses appropriate regulations on digital health at the state and federal levels and the need for continuous management as technology moves from automating healthcare to augmenting it.  
By Adam Ang | 01:48 pm | December 22, 2023
Also, Cipla has increased its stake in digital pharma solutions company GoApptiv.
By HIMSS TV | 07:00 am | December 22, 2023
AI is a tool to help people everywhere realize their health potential, said HIMSS Chief Scientific Research Officer Anne Snowden. If there was a time for learning, sharing and building a community of AI decision-making tools, it is now.  
By Jessica Hagen | 02:12 pm | December 21, 2023
Guidehealth acquired Arcadia's managed services organization and value-based care services division. It also signed an agreement to leverage its data analytics platform.
By HIMSS TV | 07:00 am | December 21, 2023
Steven Ullman, the University of Miami's director at the Center for Health Management and Policy, discusses telehealth use during and following the pandemic, why patient and provider satisfaction varies, and policy predictions for 2024.  
By Jessica Hagen | 03:47 pm | December 20, 2023
The award will support veterans' access to the California-based virtual reality company's FDA-authorized at-home chronic low back pain offering, RelieVRx.
By Jessica Hagen | 12:54 pm | December 20, 2023
The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.